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A simple high performance liquid chromatography method to assay
lidocaine hydrochloride in aqueous receiving media, following in
vitro release, is presented. Lidocaine hydrochloride was analysed
using a 5 mm LichroCART® RP-18 column (125 x 4 mm i.d.). The
mobile phase was acetonitrile: 0.05 M sodium phosphate buffer,
pH 6.0 (35:65) and 0.05% of diethylamine at a flow rate of
1 mL/min. The retention time was 7.9 min. Detection was carried
out at 210 nm at room temperature (28 oC). The method was found
to be linear in the range 1.25 to 25 mg/mL, showing average intra-
assay and inter-assay coefficients of variation below 3.5%. The
proposed method was validated for linearity, specificity, precision
and accuracy and was shown to be useful for the analysis of
lidocaine hydrochloride in in vitro release studies.
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Lidocaine hydrochloride, a widely employed local
anesthetic drug, is also used following central spinal,
epidural or peripheral administration, for topical
management of major pain. Clinics favor local
administration of anesthetics for the relief of local pain
due to the convenience of this type of application as well
as to its reduced adverse effects (Paavola et al . ,
1995,1998; Kang et al., 1999).
Poloxamer 407 is a polymer used in pharmaceutical
preparations; absence of toxicity makes them suitable for
drug delivery as well (Johnston, Miller, 1985). Poloxamer
407 gels may be used in delivery systems that require a
sol-gel transition at body temperature. The solutions are
highly viscous gels at room temperature but become
liquids at refrigerator temperature (Schmolka, 1972). This
permits injection of a fluid solution that at physiological
temperatures forms a gel in situ.
 Methods that extend the action of local anesthetics
are important, because their short duration of action limits
their use in the treatment of chronic pain. The evaluation
of thermoreversible gels for sustained release of lidocaine
hydrochloride is therefore of interest.
Studies on in vitro release of drugs from these types
of gels have received considerable attention (Paavola et
al., 1995, 1998; Barichello et al., 1999; Veyries et al.,
1999; Shin et al., 2000). In these studies, drug release is
measured using a dissolution apparatus under stirring, and
a barrier membrane of synthetic origin. The receptor
compartment contains, generally, isotonic phosphate
buffer solution as receptor medium, maintained at pH 7.2
and 37 oC to mimic physiological conditions. Samples for
analysis are removed from this compartment at regular
intervals.
Since the amount of drug in acceptor aqueous fluid
are usually small, sensitive and specific analytical
methods to their determination are usually required.
Among various assays techniques which may be
employed, high performance liquid chromatography
(HPLC) is prominent due to their potential specificity and
sensitivity.
E. Ricci Júnior, M. V. L. B. Bentley, J. M. Marchetti108
High performance liquid chromatography (HPLC)
has been used for the determination of lidocaine in serum,
urine, plasma and pharmaceutical dosage forms (Chen et
al., 1992; Lotfi et al., 1997; Kang et al., 1999). A precise
and sensitive method for the determination of lidocaine in
aqueous medium, by HPLC, from in vitro release studies
has not been reported.
The aim of the present work is to set up a rapid and




Lidocaine was obtained from Sigma-Chemical (St.
Louis, USA). Acetonitrile and methanol HPLC reagent
grade were obtained from Merck (Darmstadt, Germany).
Poloxamer 407 was obtained from BASF (USA).
Diethylamine of HPLC reagent grade was obtained from
Riedel-de-Haën (Seeize, Germany). Sodium dihydro-
genphosphate and sodium monohydrogenphosphate of
analytical grade were from Ecibra (São Paulo, Brazil) and
Nuclear (São Paulo, Brazil), respectively. Water was
obtained by following purification in a Milli-Q water
(Millipore) system.
Gel preparation
Gels were prepared using the cold method
(Schmolka, 1972). An appropriate amount of Poloxamer
407 to yield 20, 25 and 30 % gels was slowly added to cold
destilled water (5 oC) maintaining constant stirring. The
dispersion was kept in the refrigerator until a clear solution
was formed (6-12 h). An appropriated amount of lidocaine
hydrochloride to yield 2% was then dissolved in the cold
solution. Poloxamer 407 gels with 2% lidocaine
hydrochloride were autoclaved at 120 oC for 30 min and
stored in refrigerator.
Standard solutions
From a stock solution containing 1.0 mg lidocaine
hydrochloride/mL in methanol, a standard curve was
prepared at the concentration of 5, 10, 20, 50 and
100 µg/mL in methanol. For standardization, 25 mL of the
standard solutions of lidocaine hydrochloride in methanol
were transferred to glass tubes; methanol was evaporated
under air stream at room temperature, and the residues
dissolved in 100 µL of mobile phase, by vortex mixing for
30 sec. The concentration range of standard curve was
diluted four times in mobile phase and the corresponding
solution was submitted to chromatographic analysis at 1.25,
2.5, 5.0, 12.5 and 25.0 µg/mL of lidocaine hydrocloride.
Chromatographic analyses
The HPLC system employed was a Shimadzu liquid
chromatograph, model SPD 10A VP using a variable
wavelength UV detector set at 210 nm, an LC-10 ADVP
pump, a Rheodyne injector and a model CR6-A integrator.
Separation was performed on a C18 reversed-phase column
LichroCART® (Merck) 125 x 4 mm (5 mm) and a C18 pre-
column 4 x 4 mm (5 mm), at room temperature (28 oC). A
(35:65) acetonitrile:0.05 M sodium phosphate buffer pH
6.0 mixture containing 0.05 % diethylamine was used as
mobile phase, at a flow rate of 1 mL/min and injection
volume of 20 µL.
Assay validation
Lidocaine hydrochloride standard solutions
containing 1.25 to 25 µg/mL were submitted to HPLC
analysis in triplicate. Precision and linearity over this
concentration range were assessed. Precision was
calculated from the coefficient of variation (CV %) of the
standard curve and linearity was assessed from the linear
regression.
Selective study was made with: isotonic phosphate
buffer pH 7.2, 20% Poloxamer 407 gel dissolved in
isotonic phosphate buffer pH 7.2, dried 25.0 µg/mL
lidocaine hydrochloride solution in mobile phase and
lidocaine hydrochloride in isotonic phosphate buffer pH
7.2 after released from the gel.
The limit of quantification was defined by the
lowest amount of analyte that could be reproducibly
quantified with a precision below 10%. Precision was
calculated from the coefficient of variation (CV %). For
the determination of intra-assay precision of the limit of
quantification a standard curve was made in triplicate, and
six aliquots of lidocaine hydrochloride, at the concen-
tration of 0.25 µg/mL were analyzed.
In vitro release studies
Dialysis bag prepared from cellulose tubing with
diameter of 1.0 cm and extension of 3.5 cm were filled
with 0.5 g of the gel with lidocaine hydrochloride 2% w/w.
The bag was individually immersed in the recipient
containing 60 mL of the receptor media, in this case
isotonic phosphate buffer pH 7.2. The temperature was
kept at 37 oC and the receptor media was constantly stirred
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to maintain the sink conditions. At appropriate time
intervals samples were taken from the receptor media and
assayed by HPLC to determine the amount of lidocaine
released from the gel.
RESULTS
Figure 1 shows typical chromatograms of respec-
tively: dry methanol and dissolved in 100 µL of mobile
phase, isotonic phosphate buffer pH 7.2, lidocaine
hydrochloride solution 25.0 µg/mL after dry and dissolved
in mobile phase and lidocaine hydrochloride in isotonic
phosphate buffer pH 7.2 released from the gel. The
retention time of lidocaine was 7.9 min and the peak was
symmetric.
The peak heights of lidocaine correlated linearly
with concentration over the 1.25 to 25 µg/mL range. The
precision of the standard curve was below 2%. The
correlation coefficient for each standardization plot
exceeded 0.9996. The mean regression equation was
y=1438.9x-51.801, where (y) is the peak height and (x) is
the concentration of lidocaine hydrochloride in µg/mL.
FIGURE 1 - Chromatograms of: (a) isotonic phosphate buffer pH 7.2; (b) 20% Poloxamer 407 gel, dissolved in isotonic
phosphate buffer pH 7.2; (c) 25 µg/mL lidocaine hydrochloride solution in mobile phase and (d) lidocaine hydrochloride
in isotonic phosphate buffer pH 7.2 after released from Poloxamer 407 gel. Retention time of lidocaine was 7.9 min.
Chromatographic conditions: 5 mm LichroCART® RP-18 (Merck) column (125 x 4 mm i.d.), 5 mm LichroCART® RP-
18 (Merck) pre-column (4 x 4 mm i.d.), acetonitrile:0.05 M sodium phosphate buffer pH 6.0 (35:65) as mobile phase,
at a flow rate of 1 mL/min, detection at 210 nm.
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The limit of quantification was 0.25 µg/mL with a
precision below 5%.
The intra-assay precision and accuracy of the assay
(Table I) were determined by analysis of multiple spiked
samples of lidocaine hydrochloride (n=6). Aliquots of the
same samples were analyzed on six consecutive days
(n=6) for evaluation of inter-assay precision and accuracy.
The coefficients of variation for precision and accuracy
were below 3.5%.
DISCUSSION
To run the HPLC analysis the composition of the
mobile phase was, therefore, 35% acetonitrile, 65% 0.05
M sodium phosphate buffer (pH 6.0) and 0.05%
diethylamine. The retention time of lidocaine was low, 7.9
min, and the peak was symmetric.
An important consideration regarding chromato-
graphic methods is to decide whether to use an internal or
external standard. For external standardization, the
response of the analyte is plotted against concentration
(Causon, 1999). External standard was chosen because
hydrophilic lidocaine is very soluble in the receptor phase
of in vitro release studies. Lidocaine does not have to be
extracted from this receptor phase and can therefore be
directly analyzed by HPLC.
The linearity range was 1.25 to 25.0 µg/mL with
excellent correlation coefficient (> 0.9996) and the
precision of standard curve was 2%.
The limit of quantification was 0.25 µg/mL, 100 ti-
mes lower than the superior limit of the standard curve.
The precision was 5%.
The HPLC method for the determination of
lidocaine hydrochloride showed excellent repeatability,
reproducibility and accuracy (Table I). The precision and
accuracy of the method were tested by within-day (intra-
assay) and between-day (inter-assay) analyses. To deter-
mine intra-assay precision and accuracy, the standard cur-
ve was made in triplicate and six aliquots of lidocaine
hydrochloride solutions at concentrations of 2.5 and
12.5 µg/mL, respectively, were analyzed as described
above. The precision of analytical method is the measure
of the random error, defined as the agreement between
replicate measurements on the same samples. It can be
considered as having a within-assay batch component or
repeatability, which is also known as intra-assay precision.
The ability to repeat the same methodology under
different conditions or on subsequent occasions is known
as inter-assay precision or reproducibility. The accuracy of
an analytical method is a measure of the systematic error
and is defined as the agreement between the measured
value and the true value (Causon, 1999). Inter-assay
precision and accuracy were calculated by analysis of
aliquots of the same samples on six consecutive days.
Since no interfering peak from isotonic phosphate
buffer components was observed (Figure 1), the proposed
method proved to be selective for lidocaine assay in a
usual receptor medium used for in vitro release studies. A
selective analytical method should provide response
function for a number of chemical entities that may or may
not be distinguishable from each other. If the response
function is distinguishable from all others, the method can
be described as specific.
The in vitro release studies are qualitative control of
the formulations and the analytic method is important to
quantification of the lidocaine. There are many methods to
quantification of the lidocaine in serum, urine, plasma and
pharmaceutical dosage forms in the official literature or
papers but such methods are complicated or of low
sensitivity. The development of a simple, quick and
sensitive method to quantification of the lidocaine in
aqueous medium is very important.
This new method development to assay lidocaine
has sensibility and selectivity to perform the proposed
studies. The samples obtained from in vitro release studies
have low concentration of lidocaine and they have been
measured by HPLC. The method development is
important to lidocaine quantification and detection of the
interfering compounds of samples obtained from in vitro
release studies.
The simplicity, sensitivity, selectivity and short
running time of the proposed analytical method allow the
analysis of large number of samples providing an useful,
reliable means for the determination of lidocaine in
aqueous medium.
TABLE I - Analysis of the precision and accuracy of the
method for assay of lidocaine
Parameters Lidocaine
Concentration (µg/mL) 2.5 12.5
Na 6 6
Intra-assay precision (CV %b) 1.9 2.6
Inter-assay precision (CV % b) 3.5 1.1
Intra-assay Accuracy (E%c) -2.1 -2.2
Inter-assay Accuracy (E %c) 0.1 -2.0
a corresponds to the number of determinations; b coefficient
of variation; c exactness
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RESUMO
Ensaio de lidocaína por CLAE em teste de
dissolução in vitro dos géis de Poloxamer 407
Apresenta-se método simples de cromatografia líquida de
alta eficiência (CLAE) para análise da lidocaína em meio
aquoso, após estudo de liberação in vitro. A lidocaína foi
analisada usando-se coluna LichroCART RP-18 (5 mm,
125x4 mm), fase móvel constituída de acetonitrila: tam-
pão fosfato de sódio 0,05 M, pH 6 (35:65), adicionada de
0,05% de dietilamina com fluxo de 1 mL/min. O tempo de
retenção foi de 7,9 min. O comprimento de onda de aná-
lise utilizado foi de 210 nm. A linearidade do método foi
de 1,25 a 25 µg/mL com coeficiente de variação intra-
ensaio e inter-ensaio menor que 3,5 %. A metodologia
desenvolvida e validada mostrou sensibilidade e
especificidade para a realização dos estudos propostos,
considerando-se que as amostras obtidas a partir dos
estudos de liberação in vitro contêm concentrações mui-
to baixas do fármaco, além de outras substâncias do meio
de dissolução que podem interferir no doseamento. A
quantificação do fármaco e dos interferentes pode não ser
possível se for efetuada por outras metodologias analíti-
cas convencionais. Assim, o método desenvolvido é de
grande importância para a quantificação do fármaco nas
alíquotas obtidas nos ensaios de liberação in vitro.
UNITERMOS: Cloridrato de lidocaína. CLAE. Meio
Aquoso. Estudos de liberação. Gel termo-reversivel.
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